Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jay Steven Loeffler, M.D.

Co-Author

This page shows the publications co-authored by Jay Loeffler and Helen Shih.
Connection Strength

7.059
  1. Radiation therapy in the management of pituitary adenomas. J Clin Endocrinol Metab. 2011 Jul; 96(7):1992-2003.
    View in: PubMed
    Score: 0.467
  2. Radiation therapy in acromegaly. Rev Endocr Metab Disord. 2008 Mar; 9(1):59-65.
    View in: PubMed
    Score: 0.375
  3. Fractionated Proton Radiation Therapy and Hearing Preservation for Vestibular Schwannoma: Preliminary Analysis of a Prospective Phase 2 Clinical Trial. Neurosurgery. 2022 Mar 03.
    View in: PubMed
    Score: 0.247
  4. Outcome and Toxicity of Proton Therapy for Vestibular Schwannoma: A Cohort Study. Otol Neurotol. 2021 12 01; 42(10):1560-1571.
    View in: PubMed
    Score: 0.243
  5. Adjuvant Radiation Therapy Versus Surveillance After Surgical Resection of Atypical Meningiomas. Int J Radiat Oncol Biol Phys. 2021 01 01; 109(1):252-266.
    View in: PubMed
    Score: 0.222
  6. Proton therapy for head and neck paragangliomas: A single institutional experience. Head Neck. 2020 04; 42(4):670-677.
    View in: PubMed
    Score: 0.212
  7. Brachytherapy as an Adjuvant for Recurrent Atypical and Malignant Meningiomas. Neurosurgery. 2019 11 01; 85(5):E910-E916.
    View in: PubMed
    Score: 0.211
  8. Atypical Histopathological Features and the Risk of Treatment Failure in Nonmalignant Meningiomas: A Multi-Institutional Analysis. World Neurosurg. 2020 Jan; 133:e804-e812.
    View in: PubMed
    Score: 0.210
  9. Volumetric and actuarial analysis of brain necrosis in proton therapy using a novel mixture cure model. Radiother Oncol. 2020 01; 142:154-161.
    View in: PubMed
    Score: 0.209
  10. Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade glioma. Radiother Oncol. 2019 08; 137:95-101.
    View in: PubMed
    Score: 0.204
  11. Patterns of Failure Among Patients With Low-grade Glioma Treated With Proton Radiation Therapy. Pract Radiat Oncol. 2019 Jul - Aug; 9(4):e356-e361.
    View in: PubMed
    Score: 0.201
  12. Hypopituitarism After Cranial Irradiation for Meningiomas: A Single-Institution Experience. Pract Radiat Oncol. 2019 May; 9(3):e266-e273.
    View in: PubMed
    Score: 0.200
  13. Long-term impact of a faculty mentoring program in academic medicine. PLoS One. 2018; 13(11):e0207634.
    View in: PubMed
    Score: 0.197
  14. Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide. J Neurooncol. 2019 Mar; 142(1):69-77.
    View in: PubMed
    Score: 0.197
  15. Proton Stereotactic Radiosurgery for Brain Metastases: A Single-Institution Analysis of 370 Patients. Int J Radiat Oncol Biol Phys. 2018 07 15; 101(4):820-829.
    View in: PubMed
    Score: 0.189
  16. The role of proton beam therapy in central neurocytoma: A single-institution experience. Pract Radiat Oncol. 2018 Sep - Oct; 8(5):e305-e311.
    View in: PubMed
    Score: 0.187
  17. Prospective, Randomized Study of Radiation Dose Escalation With Combined Proton-Photon Therapy for Benign Meningiomas. Int J Radiat Oncol Biol Phys. 2017 11 15; 99(4):787-796.
    View in: PubMed
    Score: 0.179
  18. Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas. J Neurosurg. 2018 04; 128(4):1123-1132.
    View in: PubMed
    Score: 0.179
  19. The impact of different stereotactic radiation therapy regimens for brain metastases on local control and toxicity. Adv Radiat Oncol. 2017 Jul-Sep; 2(3):391-397.
    View in: PubMed
    Score: 0.178
  20. Spatiotemporal Fractionation Schemes for Irradiating Large Cerebral Arteriovenous Malformations. Int J Radiat Oncol Biol Phys. 2016 Jul 01; 95(3):1067-1074.
    View in: PubMed
    Score: 0.162
  21. Neurocognitive effects of proton radiation therapy in adults with low-grade glioma. J Neurooncol. 2016 Jan; 126(1):157-164.
    View in: PubMed
    Score: 0.161
  22. Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes. J Neurosurg. 2016 Jan; 124(1):106-14.
    View in: PubMed
    Score: 0.157
  23. Proton therapy for low-grade gliomas: Results from a prospective trial. Cancer. 2015 May 15; 121(10):1712-9.
    View in: PubMed
    Score: 0.151
  24. Outcomes of proton therapy for patients with functional pituitary adenomas. Int J Radiat Oncol Biol Phys. 2014 Nov 01; 90(3):532-9.
    View in: PubMed
    Score: 0.147
  25. Significance of targeted therapy and genetic alterations in EGFR, ALK, or KRAS on survival in patients with non-small cell lung cancer treated with radiotherapy for brain metastases. Neuro Oncol. 2015 Feb; 17(2):296-302.
    View in: PubMed
    Score: 0.146
  26. Pretreatment growth rate predicts radiation response in vestibular schwannomas. Int J Radiat Oncol Biol Phys. 2014 May 01; 89(1):113-9.
    View in: PubMed
    Score: 0.144
  27. Single-fraction proton beam stereotactic radiosurgery for cerebral arteriovenous malformations. Int J Radiat Oncol Biol Phys. 2014 Jun 01; 89(2):338-46.
    View in: PubMed
    Score: 0.143
  28. A comparison of critical structure dose and toxicity risks in patients with low grade gliomas treated with IMRT versus proton radiation therapy. Technol Cancer Res Treat. 2013 Feb; 12(1):1-9.
    View in: PubMed
    Score: 0.127
  29. Projected second tumor risk and dose to neurocognitive structures after proton versus photon radiotherapy for benign meningioma. Int J Radiat Oncol Biol Phys. 2012 Jul 15; 83(4):e495-500.
    View in: PubMed
    Score: 0.123
  30. Planned two-fraction proton beam stereotactic radiosurgery for high-risk inoperable cerebral arteriovenous malformations. Int J Radiat Oncol Biol Phys. 2012 Jun 01; 83(2):533-41.
    View in: PubMed
    Score: 0.121
  31. Modeling intracranial second tumor risk and estimates of clinical toxicity with various radiation therapy techniques for patients with pituitary adenoma. Technol Cancer Res Treat. 2011 Jun; 10(3):243-51.
    View in: PubMed
    Score: 0.117
  32. Outcomes after whole brain reirradiation in patients with brain metastases. Int J Radiat Oncol Biol Phys. 2012 Feb 01; 82(2):e167-72.
    View in: PubMed
    Score: 0.117
  33. Proton stereotactic radiosurgery for the treatment of benign meningiomas. Int J Radiat Oncol Biol Phys. 2011 Dec 01; 81(5):1428-35.
    View in: PubMed
    Score: 0.112
  34. Visual outcome and tumor control after conformal radiotherapy for patients with optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys. 2009 Nov 15; 75(4):1166-72.
    View in: PubMed
    Score: 0.102
  35. Late effects of CNS radiation therapy. Cancer Treat Res. 2009; 150:23-41.
    View in: PubMed
    Score: 0.099
  36. Stereotactic radiation treatment for benign meningiomas. Neurosurg Focus. 2007; 23(4):E5.
    View in: PubMed
    Score: 0.086
  37. Genetic analyses for predictors of radiation response in glioblastoma. Int J Radiat Oncol Biol Phys. 2005 Nov 01; 63(3):704-10.
    View in: PubMed
    Score: 0.078
  38. Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas. Nat Commun. 2022 Mar 14; 13(1):1325.
    View in: PubMed
    Score: 0.062
  39. Therapeutic avenues for cancer neuroscience: translational frontiers and clinical opportunities. Lancet Oncol. 2022 02; 23(2):e62-e74.
    View in: PubMed
    Score: 0.062
  40. Defining Treatment-Related Adverse Effects in Patients with Glioma: Distinctive Features of Pseudoprogression and Treatment-Induced Necrosis. Oncologist. 2020 08; 25(8):e1221-e1232.
    View in: PubMed
    Score: 0.055
  41. Post-operative radiation therapy to the surgical cavity with standard fractionation in patients with brain metastases. Sci Rep. 2020 04 14; 10(1):6331.
    View in: PubMed
    Score: 0.054
  42. C11 Methionine PET (MET-PET) Imaging of Glioblastoma for Detecting Postoperative Residual Disease and Response to Chemoradiation Therapy. Int J Radiat Oncol Biol Phys. 2018 11 15; 102(4):1024-1028.
    View in: PubMed
    Score: 0.048
  43. Temozolomide therapy for aggressive functioning pituitary adenomas refractory to surgery and radiation: a case series. Neurooncol Pract. 2018 Mar; 5(1):64-68.
    View in: PubMed
    Score: 0.044
  44. Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade. Neuro Oncol. 2016 06; 18(6):863-72.
    View in: PubMed
    Score: 0.040
  45. Underutilization of radiation therapy in patients with glioblastoma: predictive factors and outcomes. Cancer. 2014 Jan 15; 120(2):238-43.
    View in: PubMed
    Score: 0.035
  46. Natural history and role of radiation in patients with supratentorial and infratentorial WHO grade II ependymomas: results from a population-based study. J Neurooncol. 2013 Dec; 115(3):411-9.
    View in: PubMed
    Score: 0.034
  47. Patient study of in vivo verification of beam delivery and range, using positron emission tomography and computed tomography imaging after proton therapy. Int J Radiat Oncol Biol Phys. 2007 Jul 01; 68(3):920-34.
    View in: PubMed
    Score: 0.022
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.